Ramalingam Ajit's Form 4 filing
Bio-Rad Laboratories, Inc. (BIO) · filed Aug 8, 2022
- Accession no.
- 0001062993-22-017487
- Filed
- Aug 8, 2022
- Trade date
- Aug 5, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $278.2K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ramalingam AjitCIK 0001807891 | Officer (SVP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2022 | Bio-Rad A Common Stock | SSaleDisposed | −518 | $537.00 | −$278,166 | 98.5 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.